2,195
Views
92
CrossRef citations to date
0
Altmetric
Mini Review

Amyloid-β induced signaling by cellular prion protein and Fyn kinase in Alzheimer disease

&
Pages 37-41 | Received 30 Jul 2012, Accepted 12 Sep 2012, Published online: 17 Sep 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Ryan A. Townley, Angelina J. Polsinelli, Julie A. Fields, Mary M. Machulda, David T. Jones, Jonathan Graff-Radford, Kejal M. Kantarci, Val J. Lowe, Rosa V. Rademakers, Matt C. Baker, Neeraj Kumar & Bradley F. Boeve. (2020) Longitudinal clinical, neuropsychological, and neuroimaging characterization of a kindred with a 12-octapeptide repeat insertion in PRNP: the next generation. Neurocase 26:4, pages 211-219.
Read now
Alex J McDonald & Glenn L Millhauser. (2014) PrP overdrive. Prion 8:2, pages 183-191.
Read now
Berta Puig, Hermann Altmeppen & Markus Glatzel. (2014) The GPI-anchoring of PrP. Prion 8:1, pages 11-18.
Read now

Articles from other publishers (88)

Ana M. Matos, João Barros & Amélia P. Rauter. 2023. Carbohydrate‐Based Therapeutics. Carbohydrate‐Based Therapeutics 293 352 .
Arun Mittal, Rupali Sharma, Satish Sardana, Parveen Kumar Goyal, Mona Piplani & Anima Pandey. (2023) A Systematic Review of Updated Mechanistic Insights Towards Alzheimer’s Disease. CNS & Neurological Disorders - Drug Targets 22:8, pages 1232-1242.
Crossref
Amy E. Elias, Thomas A. Nuñez, Bianca Kun & Jill A. Kreiling. (2023) primiReference: a reference for analysis of primary-microRNA expression in single-nucleus sequencing data. Journal of Genetics and Genomics 50:2, pages 108-121.
Crossref
Lin Lin, Ronald S. Petralia, Lynne Holtzclaw, Ya-Xian Wang, Daniel Abebe & Dax A. Hoffman. (2022) Alzheimer's disease/dementia-associated brain pathology in aging DPP6-KO mice. Neurobiology of Disease 174, pages 105887.
Crossref
Adriana Limone, Iolanda Veneruso, Valeria D'Argenio & Daniela Sarnataro. (2022) Endosomal trafficking and related genetic underpinnings as a hub in Alzheimer's disease. Journal of Cellular Physiology 237:10, pages 3803-3815.
Crossref
Khaled S. Abd-Elrahman & Stephen S.G. Ferguson. (2022) Noncanonical Metabotropic Glutamate Receptor 5 Signaling in Alzheimer's Disease. Annual Review of Pharmacology and Toxicology 62:1, pages 235-254.
Crossref
Aishwarya Agarwal & Samrat Mukhopadhyay. (2022) Prion Protein Biology Through the Lens of Liquid-Liquid Phase Separation. Journal of Molecular Biology 434:1, pages 167368.
Crossref
Tobias Thom, Matthias Schmitz, Anna‐Lisa Fischer, Angela Correia, Susana Correia, Franc Llorens, Anna‐Villar Pique, Wiebke Möbius, Renato Domingues, Saima Zafar, Erik Stoops, Christopher J. Silva, Andre Fischer, Tiago F. Outeiro & Inga Zerr. (2021) Cellular Prion Protein Mediates α‐Synuclein Uptake, Localization, and Toxicity In Vitro and In Vivo. Movement Disorders 37:1, pages 39-51.
Crossref
Alessio Crestini, Francesca Santilli, Stefano Martellucci, Elena Carbone, Maurizio Sorice, Paola Piscopo & Vincenzo Mattei. (2021) Prions and Neurodegenerative Diseases: A Focus on Alzheimer’s Disease. Journal of Alzheimer's Disease, pages 1-16.
Crossref
Bianca Guglietti, Srisankavi Sivasankar, Sanam Mustafa, Frances Corrigan & Lyndsey E. Collins-Praino. (2021) Fyn Kinase Activity and Its Role in Neurodegenerative Disease Pathology: a Potential Universal Target?. Molecular Neurobiology 58:11, pages 5986-6005.
Crossref
George D. Vavougios, Marianthi Breza, Theodore Mavridis & Karen Angeliki Krogfelt. (2021) FYN, SARS-CoV-2, and IFITM3 in the neurobiology of Alzheimer's disease. Brain Disorders 3, pages 100022.
Crossref
Dieter Willbold, Birgit Strodel, Gunnar F. Schröder, Wolfgang Hoyer & Henrike Heise. (2021) Amyloid-type Protein Aggregation and Prion-like Properties of Amyloids. Chemical Reviews 121:13, pages 8285-8307.
Crossref
Federico Del Gallo, Susanna Bianchi, Ilaria Bertani, Massimo Messa, Laura Colombo, Claudia Balducci, Mario Salmona, Luca Imeri & Roberto Chiesa. (2020) Sleep inhibition induced by amyloid‐β oligomers is mediated by the cellular prion protein. Journal of Sleep Research 30:3.
Crossref
Efthalia Angelopoulou, Yam Nath Paudel, Thomas Julian, Mohd Farooq Shaikh & Christina Piperi. (2020) Pivotal Role of Fyn Kinase in Parkinson’s Disease and Levodopa-Induced Dyskinesia: a Novel Therapeutic Target?. Molecular Neurobiology 58:4, pages 1372-1391.
Crossref
Jonathan A. Holbrook, Heledd H. Jarosz-Griffiths, Emily Caseley, Samuel Lara-Reyna, James A. Poulter, Caroline H. Williams-Gray, Daniel Peckham & Michael F. McDermott. (2021) Neurodegenerative Disease and the NLRP3 Inflammasome. Frontiers in Pharmacology 12.
Crossref
Zeyu Song, Ying Zhou, Xiao Han, Jieling Qin & Xiaoying Tang. (2021) Recent advances in enzymeless-based electrochemical sensors to diagnose neurodegenerative diseases. Journal of Materials Chemistry B 9:5, pages 1175-1188.
Crossref
Anna S. König, Nadine S. Rösener, Lothar Gremer, Markus Tusche, Daniel Flender, Elke Reinartz, Wolfgang Hoyer, Philipp Neudecker, Dieter Willbold & Henrike Heise. (2021) Structural details of amyloid β oligomers in complex with human prion protein as revealed by solid-state MAS NMR spectroscopy. Journal of Biological Chemistry 296, pages 100499.
Crossref
Rachel E. Lackie, Jose Marques-Lopes, Valeriy G. Ostapchenko, Sarah Good, Wing-Yiu Choy, Patricija van Oosten-Hawle, Stephen H. Pasternak, Vania F. Prado & Marco A. M. Prado. (2020) Increased levels of Stress-inducible phosphoprotein-1 accelerates amyloid-β deposition in a mouse model of Alzheimer’s disease. Acta Neuropathologica Communications 8:1.
Crossref
Guanghao Liu, Kimberly L. Fiock, Yona Levites, Todd E. Golde, Marco M. Hefti & Gloria Lee. (2020) Fyn depletion ameliorates tauP301L-induced neuropathology. Acta Neuropathologica Communications 8:1.
Crossref
Si Jie Tang, Arman Fesharaki-Zadeh, Hideyuki Takahashi, Sarah Helena Nies, Levi M. Smith, Anin Luo, Annabel Chyung, Marius Chiasseu & Stephen M. Strittmatter. (2020) Fyn kinase inhibition reduces protein aggregation, increases synapse density and improves memory in transgenic and traumatic Tauopathy. Acta Neuropathologica Communications 8:1.
Crossref
Adam P. Mecca, Julia W. McDonald, Hannah R. Michalak, Tyler A. Godek, Joanna E. Harris, Erika A. Pugh, Emily C. Kemp, Ming-Kai Chen, Arash Salardini, Nabeel B. Nabulsi, Keunpoong Lim, Yiyun Huang, Richard E. Carson, Stephen M. Strittmatter & Christopher H. van Dyck. (2020) PET imaging of mGluR5 in Alzheimer’s disease. Alzheimer's Research & Therapy 12:1.
Crossref
Jieling Qin, Soochan Kim, Misuk Cho & Youngkwan Lee. (2020) Hierarchical and ultra-sensitive amyloid beta oligomer sensor for practical applications. Chemical Engineering Journal 401, pages 126055.
Crossref
Unekwu M. Yakubu, Celso S. G. Catumbela, Rodrigo Morales & Kevin A. Morano. (2020) Understanding and exploiting interactions between cellular proteostasis pathways and infectious prion proteins for therapeutic benefit. Open Biology 10:11.
Crossref
Ana M. de Matos, M. Teresa Blázquez-Sánchez, Andreia Bento-Oliveira, Rodrigo F. M. de Almeida, Rafael Nunes, Pedro E. M. Lopes, Miguel Machuqueiro, Joana S. Cristóvão, Cláudio M. Gomes, Cleide S. Souza, Imane G. El Idrissi, Nicola A. Colabufo, Ana Diniz, Filipa Marcelo, M. Conceição Oliveira, Óscar López, José G. Fernandez-Bolaños, Philipp Dätwyler, Beat Ernst, Ke Ning, Claire Garwood, Beining Chen & Amélia P. Rauter. (2020) Glucosylpolyphenols as Inhibitors of Aβ-Induced Fyn Kinase Activation and Tau Phosphorylation: Synthesis, Membrane Permeability, and Exploratory Target Assessment within the Scope of Type 2 Diabetes and Alzheimer’s Disease. Journal of Medicinal Chemistry 63:20, pages 11663-11690.
Crossref
Elham Rezvani Boroujeni, Seyed Masoud Hosseini, Giulia Fani, Cristina Cecchi & Fabrizio Chiti. (2020) Soluble Prion Peptide 107–120 Protects Neuroblastoma SH-SY5Y Cells against Oligomers Associated with Alzheimer’s Disease. International Journal of Molecular Sciences 21:19, pages 7273.
Crossref
Elsa Ghirardini, Elena Restelli, Raffaella Morini, Ilaria Bertani, Davide Ortolan, Fabio Perrucci, Davide Pozzi, Michela Matteoli & Roberto Chiesa. (2020) Mutant prion proteins increase calcium permeability of AMPA receptors, exacerbating excitotoxicity. PLOS Pathogens 16:7, pages e1008654.
Crossref
Berta Puig, Denise Yang, Santra Brenna, Hermann Clemens Altmeppen & Tim Magnus. (2020) Show Me Your Friends and I Tell You Who You Are: The Many Facets of Prion Protein in Stroke. Cells 9:7, pages 1609.
Crossref
Richard Kanyo, Patricia L.A. Leighton, Gavin J. Neil, Laszlo F. Locskai & W. Ted Allison. (2020) Amyloid-β precursor protein mutant zebrafish exhibit seizure susceptibility that depends on prion protein. Experimental Neurology 328, pages 113283.
Crossref
Rosalina Gavín, Laia Lidón, Isidre Ferrer & José Antonio del Río. (2020) The Quest for Cellular Prion Protein Functions in the Aged and Neurodegenerating Brain. Cells 9:3, pages 591.
Crossref
James A. Mastrianni. 2020. Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease. Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease 363 383 .
Minkyung Lee, Hae-June Lee, Ye Ji Jeong, Se Jong Oh, Kyung Jun Kang, Sang Jin Han, Kyung Rok Nam, Yong Jin Lee, Kyo Chul Lee, Young Hoon Ryu, In Young Hyun & Jae Yong Choi. (2019) Age dependency of mGluR5 availability in 5xFAD mice measured by PET. Neurobiology of Aging 84, pages 208-216.
Crossref
Sushma & Amal Chandra Mondal. (2019) Role of GPCR signaling and calcium dysregulation in Alzheimer's disease. Molecular and Cellular Neuroscience 101, pages 103414.
Crossref
Agnese De Mario, Caterina Peggion, Maria Lina Massimino, Rosa Pia Norante, Alessandra Zulian, Alessandro Bertoli & Maria Catia Sorgato. (2019) The Link of the Prion Protein with Ca2+ Metabolism and ROS Production, and the Possible Implication in Aβ Toxicity. International Journal of Molecular Sciences 20:18, pages 4640.
Crossref
Ana M. Matos, Teresa Man, Imane Idrissi, Cleide C. Souza, Emma Mead, Charlotte Dunbar, Joanna Wolak, Maria C. Oliveira, David Evans, James Grayson, Benjamin Partridge, Claire Garwood, Ke Ning, Gary Sharman, Beining Chen & Amélia P. Rauter. (2019) Discovery of N -methylpiperazinyl flavones as a novel class of compounds with therapeutic potential against Alzheimer’s disease: synthesis, binding affinity towards amyloid β oligomers (Aβo) and ability to disrupt Aβo-PrP C interactions . Pure and Applied Chemistry 91:7, pages 1107-1136.
Crossref
Kefeng Qin, Lili Zhao, Crystal Gregory, Ani Solanki & James A. Mastrianni. (2019) “Dual Disease” TgAD/GSS mice exhibit enhanced Alzheimer’s disease pathology and reveal PrPC-dependent secretion of Aβ. Scientific Reports 9:1.
Crossref
Xicai Liang, Yingjia Yao, Ying Lin, Liang Kong, Honghe Xiao, Yue Shi & Jingxian Yang. (2019) Panaxadiol inhibits synaptic dysfunction in Alzheimer's disease and targets the Fyn protein in APP/PS1 mice and APP-SH-SY5Y cells. Life Sciences 221, pages 35-46.
Crossref
Adam P. Mecca. 2019. Brain Imaging. Brain Imaging 139 165 .
Jiqing Cao, Jianwei Hou, Jing Ping & Dongming Cai. (2018) Advances in developing novel therapeutic strategies for Alzheimer’s disease. Molecular Neurodegeneration 13:1.
Crossref
Steven J. Collins, Carolin Tumpach, Bradley R. Groveman, Simon C. Drew & Cathryn L. Haigh. (2018) Prion protein cleavage fragments regulate adult neural stem cell quiescence through redox modulation of mitochondrial fission and SOD2 expression. Cellular and Molecular Life Sciences 75:17, pages 3231-3249.
Crossref
José A. del Río, Isidre Ferrer & Rosalina Gavín. (2018) Role of cellular prion protein in interneuronal amyloid transmission. Progress in Neurobiology 165-167, pages 87-102.
Crossref
Minkyung Lee, Hae-June Lee, In Suh Park, Ji-Ae Park, Yeon Ju Kwon, Young Hoon Ryu, Chul Hoon Kim, Joo Hyun Kang, In Young Hyun, Kyo Chul Lee & Jae Yong Choi. (2018) Aβ pathology downregulates brain mGluR5 density in a mouse model of Alzheimer. Neuropharmacology 133, pages 512-517.
Crossref
Hannah Carr, Tyler C. Alexander, Thomas Groves, Frederico Kiffer, Jing Wang, Elvin Price, Marjan Boerma & Antiño R. Allen. (2018) Early effects of 16 O radiation on neuronal morphology and cognition in a murine model. Life Sciences in Space Research 17, pages 63-73.
Crossref
Saak V. Ovsepian, Valerie B. O'Leary, Laszlo Zaborszky, Vasilis Ntziachristos & J. Oliver Dolly. (2018) Synaptic vesicle cycle and amyloid β: Biting the hand that feeds. Alzheimer's & Dementia 14:4, pages 502-513.
Crossref
Laura Urrea, Miriam Segura-Feliu, Masami Masuda-Suzukake, Arnau Hervera, Lucas Pedraz, José Manuel García Aznar, Miquel Vila, Josep Samitier, Eduard Torrents, Isidro Ferrer, Rosalina Gavín, Masato Hagesawa & José Antonio del Río. (2017) Involvement of Cellular Prion Protein in α-Synuclein Transport in Neurons. Molecular Neurobiology 55:3, pages 1847-1860.
Crossref
Andreas Kulawik, Henrike Heise, Christian Zafiu, Dieter Willbold & Oliver Bannach. (2018) Advancements of the sFIDA method for oligomer‐based diagnostics of neurodegenerative diseases . FEBS Letters 592:4, pages 516-534.
Crossref
Rafael Linden, Vilma R. Martins & Marco A. M. Prado. 2018. Encyclopedia of Signaling Molecules. Encyclopedia of Signaling Molecules 4164 4180 .
Ji Won Um & Jaewon Ko. (2017) Neural Glycosylphosphatidylinositol-Anchored Proteins in Synaptic Specification. Trends in Cell Biology 27:12, pages 931-945.
Crossref
Diana G Ferreira, Mariana Temido-Ferreira, Hugo Vicente Miranda, Vânia L Batalha, Joana E Coelho, Éva M Szegö, Inês Marques-Morgado, Sandra H Vaz, Jeong Seop Rhee, Matthias Schmitz, Inga Zerr, Luísa V Lopes & Tiago F Outeiro. (2017) α-synuclein interacts with PrPC to induce cognitive impairment through mGluR5 and NMDAR2B. Nature Neuroscience 20:11, pages 1569-1579.
Crossref
Saima Zafar, Mohsin Shafiq, Neelam Younas, Matthias Schmitz, Isidre Ferrer & Inga Zerr. (2017) Prion Protein Interactome: Identifying Novel Targets in Slowly and Rapidly Progressive Forms of Alzheimer’s Disease. Journal of Alzheimer's Disease 59:1, pages 265-275.
Crossref
Jun Zhao, Buyong Ma & Ruth Nussinov. (2016) Compilation and Analysis of Enzymes, Engineered Antibodies, and Nanoparticles Designed to Interfere with Amyloid‐β Aggregation. Israel Journal of Chemistry 57:7-8, pages 622-633.
Crossref
Katarzyna M Grochowska, PingAn Yuanxiang, Julia Bär, Rajeev Raman, Gemma Brugal, Giriraj Sahu, Michaela Schweizer, Arthur Bikbaev, Stephan Schilling, Hans‐Ulrich Demuth & Michael R Kreutz. (2017) Posttranslational modification impact on the mechanism by which amyloid‐β induces synaptic dysfunction. EMBO reports 18:6, pages 962-981.
Crossref
Ravi Rajmohan & P. Hemachandra Reddy. (2017) Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer’s disease Neurons. Journal of Alzheimer's Disease 57:4, pages 975-999.
Crossref
Rafael Linden. (2017) The Biological Function of the Prion Protein: A Cell Surface Scaffold of Signaling Modules. Frontiers in Molecular Neuroscience 10.
Crossref
Saioa R. Elezgarai & Emiliano Biasini. (2016) Common therapeutic strategies for prion and Alzheimer’s diseases. Biological Chemistry 397:11, pages 1115-1124.
Crossref
Ádám Annus, Anett Csáti & László Vécsei. (2016) Prion diseases: New considerations. Clinical Neurology and Neurosurgery 150, pages 125-132.
Crossref
Shaoheng Li, Yuhui Yan, Yanan Jiao, Zhong Gao, Yang Xia, Liang Kong, Yingjia Yao, Zhenyu Tao, Jie Song, Yaping Yan, Guangxian Zhang & Jingxian Yang. (2016) Neuroprotective Effect of Osthole on Neuron Synapses in an Alzheimer?s Disease Cell Model via Upregulation of MicroRNA-9. Journal of Molecular Neuroscience 60:1, pages 71-81.
Crossref
Andrzej Maciejewski, Valeriy G. Ostapchenko, Flavio H. Beraldo, Vania F. Prado, Marco A.M. Prado & Wing-Yiu Choy. (2016) Domains of STIP1 responsible for regulating PrPC-dependent amyloid-β oligomer toxicity. Biochemical Journal 473:14, pages 2119-2130.
Crossref
Ashfaqul Hoque, M. Iqbal Hossain, S. Sadia Ameen, Ching-Seng Ang, Nicholas Williamson, Dominic C.H. Ng, Anderly C. Chueh, Carli Roulston & Heung-Chin Cheng. (2016) A beacon of hope in stroke therapy—Blockade of pathologically activated cellular events in excitotoxic neuronal death as potential neuroprotective strategies. Pharmacology & Therapeutics 160, pages 159-179.
Crossref
Tania Massignan, Sara Cimini, Claudia Stincardini, Milica Cerovic, Ilaria Vanni, Saioa R. Elezgarai, Jorge Moreno, Matteo Stravalaci, Alessandro Negro, Valeria Sangiovanni, Elena Restelli, Geraldina Riccardi, Marco Gobbi, Joaquín Castilla, Tiziana Borsello, Romolo Nonno & Emiliano Biasini. (2016) A cationic tetrapyrrole inhibits toxic activities of the cellular prion protein. Scientific Reports 6:1.
Crossref
Takashi Miyamoto, Daniel Kim, Joseph A. Knox, Erik Johnson & Lennart Mucke. (2016) Increasing the Receptor Tyrosine Kinase EphB2 Prevents Amyloid-β-induced Depletion of Cell Surface Glutamate Receptors by a Mechanism That Requires the PDZ-binding Motif of EphB2 and Neuronal Activity. Journal of Biological Chemistry 291:4, pages 1719-1734.
Crossref
Adriano Aguzzi & Asvin K.K. Lakkaraju. (2016) Cell Biology of Prions and Prionoids: A Status Report. Trends in Cell Biology 26:1, pages 40-51.
Crossref
L.T. Haas & S.M. Strittmatter. 2016. Developing Therapeutics for Alzheimer's Disease. Developing Therapeutics for Alzheimer's Disease 227 250 .
Min Xia, Xiaofang Cheng, Ruofan Yi, Dong Gao & Jiaxiang Xiong. (2014) The Binding Receptors of Aβ: an Alternative Therapeutic Target for Alzheimer’s Disease. Molecular Neurobiology 53:1, pages 455-471.
Crossref
Rafael Linden, Vilma R. Martins & Marco A. M. Prado. 2016. Encyclopedia of Signaling Molecules. Encyclopedia of Signaling Molecules 1 17 .
Lina Ma, Yun Li & Rong Wang. (2015) Drebrin and cognitive impairment. Clinica Chimica Acta 451, pages 121-124.
Crossref
Takashi Amemori, Pavla Jendelova, Jiri Ruzicka, Lucia Urdzikova & Eva Sykova. (2015) Alzheimer’s Disease: Mechanism and Approach to Cell Therapy. International Journal of Molecular Sciences 16:11, pages 26417-26451.
Crossref
Agnese De Mario, Angela Castellani, Caterina Peggion, Maria Lina Massimino, Dmitry Lim, Andrew F. Hill, M. Catia Sorgato & Alessandro Bertoli. (2015) The prion protein constitutively controls neuronal store-operated Ca2+ entry through Fyn kinase. Frontiers in Cellular Neuroscience 9.
Crossref
Nunzio Iraci, Claudia Stincardini, Maria Letizia Barreca & Emiliano Biasini. (2015) Decoding the function of the N-terminal tail of the cellular prion protein to inspire novel therapeutic avenues for neurodegenerative diseases. Virus Research 207, pages 62-68.
Crossref
Takayuki OhnishiMasako YanazawaTomoya SasaharaYasuki KitamuraHidekazu HiroakiYugo FukazawaIsao KiiTakashi NishiyamaAkiyoshi KakitaHiroyuki TakedaAkihide TakeuchiYoshie AraiAkane ItoHitomi KomuraHajime HiraoKaori SatomuraMasafumi InoueShin-ichi MuramatsuKo MatsuiMari TadaMichio SatoEri SaijoYoshiki ShigemitsuSatoko SakaiYoshitaka UmetsuNatsuko GodaNaomi TakinoHitoshi TakahashiMasatoshi HagiwaraTatsuya SawasakiGenji IwasakiYu NakamuraYo-ichi NabeshimaDavid B. Teplow & Minako Hoshi. (2015) Na, K-ATPase α3 is a death target of Alzheimer patient amyloid-β assembly. Proceedings of the National Academy of Sciences 112:32.
Crossref
Jennifer Mayordomo-Cava, Javier Yajeya, Juan D. Navarro-L?pez & Lydia Jim?nez-D?az. (2015) Amyloid-?(25-35) Modulates the Expression of GirK and KCNQ Channel Genes in the Hippocampus. PLOS ONE 10:7, pages e0134385.
Crossref
C. Vergara, L. Ordóñez-Gutiérrez, F. Wandosell, I. Ferrer, J. A. del Río & R. Gavín. (2014) Role of PrPC Expression in Tau Protein Levels and Phosphorylation in Alzheimer’s Disease Evolution. Molecular Neurobiology 51:3, pages 1206-1220.
Crossref
Kirsten L. Viola & William L. Klein. (2015) Amyloid ? oligomers in Alzheimer?s disease pathogenesis, treatment, and diagnosis. Acta Neuropathologica 129:2, pages 183-206.
Crossref
Akikazu Sakudo & Takashi Onodera. (2015) Prion protein (PrP) gene-knockout cell lines: insight into functions of the PrP. Frontiers in Cell and Developmental Biology 2.
Crossref
Laura T. Haas, Mikhail A. Kostylev & Stephen M. Strittmatter. (2014) Therapeutic Molecules and Endogenous Ligands Regulate the Interaction between Brain Cellular Prion Protein (PrPC) and Metabotropic Glutamate Receptor 5 (mGluR5). Journal of Biological Chemistry 289:41, pages 28460-28477.
Crossref
Arundhathi Venkatasubramaniam, Alexander Drude & Theresa Good. (2014) Role of N-terminal residues in Aβ interactions with integrin receptor and cell surface. Biochimica et Biophysica Acta (BBA) - Biomembranes 1838:10, pages 2568-2577.
Crossref
Silvia Bolognin, Erika Lorenzetto, Giovanni Diana & Mario Buffelli. (2014) The Potential Role of Rho GTPases in Alzheimer's Disease Pathogenesis. Molecular Neurobiology 50:2, pages 406-422.
Crossref
Y. Y. Stroylova, G. G. Kiselev, E. V. Schmalhausen & V. I. Muronetz. (2014) Prions and chaperones: Friends or foes?. Biochemistry (Moscow) 79:8, pages 761-775.
Crossref
Georges Mairet-Coello & Franck Polleux. (2014) Involvement of ‘stress–response’ kinase pathways in Alzheimer's disease progression. Current Opinion in Neurobiology 27, pages 110-117.
Crossref
Bianca Da Costa Dias, Katarina Jovanovic, Danielle Gonsalves, Kiashanee Moodley, Uwe Reusch, Stefan Knackmuss, Marc S. Weinberg, Melvyn Little & Stefan F. T. Weiss. (2014) The 37kDa/67kDa Laminin Receptor acts as a receptor for Aβ42 internalization. Scientific Reports 4:1.
Crossref
E.I. Solntseva, N.A. Kapai, O.V. Popova, P.D. Rogozin & V.G. Skrebitsky. (2014) The involvement of sigma1 receptors in donepezil-induced rescue of hippocampal LTP impaired by beta-amyloid peptide. Brain Research Bulletin 106, pages 56-61.
Crossref
Katarina Jovanovic, Ben Loos, Bianca Da Costa Dias, Clement Penny & Stefan F. T. Weiss. (2014) High Resolution Imaging Study of Interactions between the 37 kDa/67 kDa Laminin Receptor and APP, Beta-Secretase and Gamma-Secretase in Alzheimer's Disease. PLoS ONE 9:6, pages e100373.
Crossref
Dezhi Liao, Eric C. Miller & Peter J. Teravskis. (2014) Tau acts as a mediator for A lzheimer's disease‐related synaptic deficits . European Journal of Neuroscience 39:7, pages 1202-1213.
Crossref
Cassia R. Overk & Eliezer Masliah. (2014) Pathogenesis of synaptic degeneration in Alzheimer's disease and Lewy body disease. Biochemical Pharmacology 88:4, pages 508-516.
Crossref
Frank Dohler, Diego Sepulveda-Falla, Susanne Krasemann, Hermann Altmeppen, Hartmut Schlüter, Diana Hildebrand, Inga Zerr, Jakob Matschke & Markus Glatzel. (2014) High molecular mass assemblies of amyloid-β oligomers bind prion protein in patients with Alzheimer’s disease. Brain 137:3, pages 873-886.
Crossref
Alexandra Grubman & Anthony R. White. (2014) Copper as a key regulator of cell signalling pathways. Expert Reviews in Molecular Medicine 16.
Crossref
Cristina Cecchi & Massimo Stefani. (2013) The amyloid-cell membrane system. The interplay between the biophysical features of oligomers/fibrils and cell membrane defines amyloid toxicity. Biophysical Chemistry 182, pages 30-43.
Crossref
Ji Won Um, Adam C. Kaufman, Mikhail Kostylev, Jacqueline K. Heiss, Massimiliano Stagi, Hideyuki Takahashi, Meghan E. Kerrisk, Alexander Vortmeyer, Thomas Wisniewski, Anthony J. Koleske, Erik C. Gunther, Haakon B. Nygaard & Stephen M. Strittmatter. (2013) Metabotropic Glutamate Receptor 5 Is a Coreceptor for Alzheimer Aβ Oligomer Bound to Cellular Prion Protein. Neuron 79:5, pages 887-902.
Crossref
Mino Kang, Su Yeon Kim, Seong Soo A An & Young Ran Ju. (2013) Characterizing affinity epitopes between prion protein and β-amyloid using an epitope mapping immunoassay. Experimental & Molecular Medicine 45:8, pages e34-e34.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.